0QLR Novartis AG Novartis receives positive CHMP opinion for Kymriah® for treating two aggressive blood cancers, marking important medical advance for patients in Europe
NVT Northern Venture Trust Notification of Transaction by Person Discharging Managerial Responsibilities (“PDMR”)